Verifying the Effectiveness of the NUsurface® System
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Elliott B Hershman, MD
Lenox Hill Hospital NYC
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Orthoindy
Indianapolis, Indiana, United States
- Brigham and Woman'S Hospital
Boston, Massachusetts, United States
- New England Baptist Hospital
Roxbury Crossing, Massachusetts, United States
- Capital Region Orthopaedics
Albany, New York, United States
- Lenox Hill Hospital
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Ohio State University Medical Center
Columbus, Ohio, United States
- Orthosouth
Memphis, Tennessee, United States
- Advanced Orthopaedics
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2014
- Primary completion
- 30 Jun 2021
- Completion
- 3 May 2022
- Last update posted
- 22 Sept 2026
- Registered enrollment
- 337
- Registry id
- NCT02108496
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.